Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Experts Tout Immediate Quadruple Therapy for HFrEF PatientsThere is growing support among opinion leaders that patients newly diagnosed with heart failure with reduced ejection fraction
should start immediately on all four foundational drug regiments.
Vericiguat Benefits Even With High Adherence to HFrEF MedsThrow every recommended med at low-EF heart failure, and vericiguat on top further cuts clinical risk, says a new VICTORIA
analysis. It also hints at potential synergy with a mainstay drug class.
